Compare RNST & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RNST | TXG |
|---|---|---|
| Founded | 1904 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.6B |
| IPO Year | 1997 | 2019 |
| Metric | RNST | TXG |
|---|---|---|
| Price | $41.99 | $29.17 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 15 |
| Target Price | ★ $43.00 | $20.25 |
| AVG Volume (30 Days) | 651.7K | ★ 2.9M |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.31% | N/A |
| EPS Growth | N/A | ★ 76.97 |
| EPS | ★ 0.94 | N/A |
| Revenue | N/A | ★ $245,893,000.00 |
| Revenue This Year | $31.72 | N/A |
| Revenue Next Year | $4.67 | $7.33 |
| P/E Ratio | $44.16 | ★ N/A |
| Revenue Growth | N/A | ★ 68.06 |
| 52 Week Low | $33.04 | $10.17 |
| 52 Week High | $42.40 | $35.65 |
| Indicator | RNST | TXG |
|---|---|---|
| Relative Strength Index (RSI) | 62.61 | 58.88 |
| Support Level | $38.90 | $16.11 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.80 | 2.33 |
| MACD | 0.08 | 0.24 |
| Stochastic Oscillator | 86.92 | 49.78 |
Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has two reportable segments: Community banks and Wealth management. With its Community Banks segment, the company provides a range of financial services to individuals and small businesses. The Wealth management segment provides a range of services, including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).